Non-Dose-Dependent Changes in Liver Enzyme Levels of Children With Epilepsy on Treatment With Sodium Valproate
Background: Sodium valproate (VPA) is considered as the drug of choice for the treatment of generalized epilepsy in children. Sodium Valproate may be hepatotoxic. Aim: To assess the level of derangement of liver enzymes in children with epilepsy on treatment with sodium valproate. Methods: A cohort...
Saved in:
Main Authors: | Aduragbenro Deborah A. Adedapo (Author), Winifred Eseoghene Demaki (Author), IkeOluwa Lagunju (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valproate for Intractable Epilepsy
by: J Gordon Millichap
Published: (1992) -
Valproate Hepatotoxicity in Children with Epilepsy
by: J Gordon Millichap
Published: (1987) -
Endocrine Effects of Valproate in Adolescent Girls with Epilepsy
by: J Gordon Millichap
Published: (2007) -
Psoriasiform Drug Eruption Associated with Sodium Valproate
by: Gulen Gul Mert, et al.
Published: (2013) -
Suspected hepatotoxicity and thrombocytopenia: Sodium valproate and carbamazepine
by: Siddhi Umarje, et al.
Published: (2018)